Immunocore Holdings PLC Sponsored ADR (IMCR) is Attracting Investor Attention: Here is What You Should KnowZacks Investment Research • 03/30/23
Immunocore Holdings PLC Sponsored ADR (IMCR) Is a Trending Stock: Facts to Know Before Betting on ItZacks Investment Research • 03/16/23
Investors Heavily Search Immunocore Holdings PLC Sponsored ADR (IMCR): Here is What You Need to KnowZacks Investment Research • 02/24/23
Immunocore to Report Fourth Quarter and Full Year 2022 Earnings and Host Call on March 1, 2023GlobeNewsWire • 02/23/23
Immunocore announces initial Phase 1 safety and pharmacodynamic activity data with first soluble TCR therapy for people living with HIVGlobeNewsWire • 02/22/23
Immunocore Holdings PLC Sponsored ADR (IMCR) Surges 6.5%: Is This an Indication of Further Gains?Zacks Investment Research • 02/14/23
IPO Stock Of The Week: Biotech Leader Immunocore Approaches Latest Buy PointInvestors Business Daily • 02/03/23
Here is What to Know Beyond Why Immunocore Holdings PLC Sponsored ADR (IMCR) is a Trending StockZacks Investment Research • 02/01/23
IPO Stock Of The Week: Biotech Leader Immunocore Shows New Buy PointInvestors Business Daily • 01/20/23
Is Immunocore (IMCR) Stock Outpacing Its Medical Peers This Year?Zacks Investment Research • 01/19/23
Immunocore Holdings PLC Sponsored ADR (IMCR) Soars 6.9%: Is Further Upside Left in the Stock?Zacks Investment Research • 01/13/23
Immunocore announces strategic priorities including pipeline expansion for 2023 -2024GlobeNewsWire • 01/09/23